189 related articles for article (PubMed ID: 18957623)
21. Triptans, SSRIs/SNRIs and serotonin syndrome.
Rothrock JF
Headache; 2010 Jun; 50(6):1101-2. PubMed ID: 20618824
[No Abstract] [Full Text] [Related]
22. Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?
Spies PE; Pot JLWH; Willems RPJ; Bos JM; Kramers C
Eur J Hosp Pharm; 2017 Mar; 24(2):124-127. PubMed ID: 31156918
[TBL] [Abstract][Full Text] [Related]
23. [SSRI and SNRI treatment in children and adolescents. Current views of the benefits and risks].
Holtkamp K; Herpertz-Dahlmann B
Nervenarzt; 2008 Nov; 79(11):1237-8, 1240, 1243-4, passim. PubMed ID: 18958442
[TBL] [Abstract][Full Text] [Related]
24. Triptans, serotonin agonists, and serotonin syndrome (serotonin toxicity): a review.
Gillman PK
Headache; 2010 Feb; 50(2):264-72. PubMed ID: 19925619
[TBL] [Abstract][Full Text] [Related]
25. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome.
Bailey AL; Makela EH; Asberg K
J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838
[TBL] [Abstract][Full Text] [Related]
26. Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice.
Tepper SJ
Headache; 2012 Feb; 52(2):195-7. PubMed ID: 22221260
[No Abstract] [Full Text] [Related]
27. Serotonin syndrome in the deployed setting.
Lawyer TI; Jensen J; Welton RS
Mil Med; 2010 Dec; 175(12):950-2. PubMed ID: 21265300
[TBL] [Abstract][Full Text] [Related]
28. Tolerability of serotonin norepinephrine reuptake inhibitor antidepressants.
Montgomery SA
CNS Spectr; 2008 Jul; 13(7 Suppl 11):27-33. PubMed ID: 18622372
[TBL] [Abstract][Full Text] [Related]
29. Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release.
Peniston JH; Hu X; Potts SL; Wieman MS; Turk DC
Postgrad Med; 2012 Mar; 124(2):114-22. PubMed ID: 22437221
[TBL] [Abstract][Full Text] [Related]
30. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
Alrasheed M; Hincapie AL; Guo JJ
J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
[TBL] [Abstract][Full Text] [Related]
31. Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery.
Starlinger P; Pereyra D; Hackl H; Ortmayr G; Braunwarth E; Santol J; Najarnia S; Driedger MR; Gregory L; Alva-Ruiz R; Glasgow A; Assinger A; Nagorney DM; Habermann EB; Staetttner S; Cleary SP; Smoot RL; Gruenberger T
Hepatology; 2021 May; 73(5):1956-1966. PubMed ID: 33078426
[TBL] [Abstract][Full Text] [Related]
32. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
33. [Serotonin syndrome].
Yamawaki S; Iwamoto Y
Ryoikibetsu Shokogun Shirizu; 2003; (38):370-3. PubMed ID: 12877005
[No Abstract] [Full Text] [Related]
34. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
35. Cerebrovascular, Cardiovascular, and Mortality Events in New Users of Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: A Propensity Score-Matched Population-Based Study.
Leong C; Alessi-Severini S; Enns MW; Nie Y; Sareen J; Bolton J; Prior HJ; Chateau D
J Clin Psychopharmacol; 2017 Jun; 37(3):332-340. PubMed ID: 28383363
[TBL] [Abstract][Full Text] [Related]
36. Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.
Perry NK
Postgrad Med J; 2000 Apr; 76(894):254-6. PubMed ID: 10727586
[TBL] [Abstract][Full Text] [Related]
37. A Case of an Older Adult Patient and Drugs Associated with Serotonin Syndrome.
Nguyen T; Sin B
Consult Pharm; 2015 Aug; 30(8):455-8. PubMed ID: 26260641
[TBL] [Abstract][Full Text] [Related]
38. Drug interactions with triptans : which are clinically significant?
Rolan PE
CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
[TBL] [Abstract][Full Text] [Related]
39. Is an FDA alert harming patients?
Schuman E
JAAPA; 2009 May; 22(5):55. PubMed ID: 19469393
[No Abstract] [Full Text] [Related]
40. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
